title: Rhodotorula mucilaginosa lymphadenitis in an HIV-infected patient.
abstract: We report a case of lymphadenitis due to Rhodotorula mucilaginosa in a man with well-controlled HIV infection. The diagnosis was established microbiologically by positive lymph tissue cultures, and clinically by responses of lymphadenitis to antifungal therapy. The patient was asymptomatic and was treated with itraconazole 200mg orally once daily as an outpatient. Clinical response was evident within three weeks with improvement of lymphadenopathy on serial computed tomography scans. Lymphadenopathy resolved completely after 8 months of itraconazole therapy and had not recurred 9 months after treatment was stopped.
authors.affiliation: Medical/Surgical Patient Care Center, James J. Peters Veterans Affairs Medical Center, Bronx, New York 10468, USA. horatio.fung@va.gov
authors.forename: Horatio B
authors.initials: HB
authors.lastname: Fung
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Martyn
authors.forename: Azra
authors.initials: A
authors.lastname: Shahidi
authors.forename: Sheldon T
authors.initials: ST
authors.lastname: Brown
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology*; D000935:Antifungal Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008198:Lymph Nodes / Q000382:microbiology; D008199:Lymphadenitis / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000382:microbiology; D012248:Rhodotorula / Q000145:classification / Q000302:isolation & purification*
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole